Marks Lashes Out At FDA Vaccine Advisers After COVID-19 Booster Vote

Tensions around COVID-19 vaccine booster discussions were on full display Friday (Sept. 17) as FDA’s vaccine advisers voted in favor of authorizing a booster dose of Pfizer’s COVID-19 vaccine for certain populations but overwhelmingly voted against approving the extra shot for people 16 and older, prompting FDA biologics center Director Peter Marks to remind committee members they ultimately do not determine FDA’s final approval decision. “We are not bound at FDA by your vote, just so you understand that,” Marks...